Serum Protein Profiling of Smear-Positive and Smear-Negative Pulmonary Tuberculosis Using SELDI-TOF Mass Spectrometry

被引:0
|
作者
Qi Liu
Xuerong Chen
Chaojun Hu
Renqing Zhang
Ji Yue
Guihui Wu
Xiaoping Li
Yunhong Wu
Fuqiang Wen
机构
[1] Sichuan University,Division of Pulmonary Disease, State Key Laboratory of Biotherapy, Department of Respiratory Medicine, West China Hospital, West China School of Medicine
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Clinical Laboratory, Peking Union Medical College Hospital
[3] Chengdu Infectious Disease Hospital,undefined
[4] Chengdu Tuberculosis Hospital,undefined
[5] Chengdu Hospital Affiliated to Tibet Autonomous Region Government,undefined
来源
Lung | 2010年 / 188卷
关键词
SELDI-TOF; Smear-positive pulmonary tuberculosis; Smear-negative pulmonary tuberculosis; Proteomics; Protein profiling; ProteinChip;
D O I
暂无
中图分类号
学科分类号
摘要
The focus of this study was to detect novel sera biomarkers for smear-positive and smear-negative pulmonary tuberculosis and to establish respective diagnostic models using the surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) technique. A total of 155 sera samples from smear-positive pulmonary tuberculosis (SPPTB) and smear-negative pulmonary tuberculosis (SNPTB) patients and non-tuberculosis (non-TB) controls were analyzed with SELDI-TOF MS. The study was divided into a preliminary training set and a blinded testing set. A classification tree of spectra derived from 31 SPPTB patients, 22 SNPTB patients, and 42 non-TB controls were used to develop an optimal classification tree that discriminated them respectively in the training set. Then, the validity of the classification tree was challenged with another independent blinded testing set, which included 20 SPPTB patients, 14 SNPTB patients, and 26 non-TB controls. SNPTB patients and non-TB controls also were analyzed alone using the same method. The optimal decision tree model with a panel of nine biomarkers with mass:charge ratios (m/z) of 4821.45, 3443.22, 9284.93, 4473.86, 4702.84, 3443.22, 5343.26, 3398.27, and 3193.61 determined in the training set could detect 93.55%, 95.46%, and 88.09% accuracy for classifying SPPTB patients, SNPTB patients, and non-TB controls specimens, respectively. Validation of an independent, blinded testing set gave an accuracy of 80.77% for controls, 75.00% for SPPTB, and 71.43% for SNPTB samples using the same classification tree. With the peaks displaying differences between SNPTB patients and non-TB controls, a simplified dendrogram (m/z 4821.45, 4792.74) demonstrated classification efficacy of 85.94% (sensitivity 86.36% and specificity 85.71%) for distinguishing SNPTB patients from non-TB controls. The independent blinded testing set containing 14 SNPTB patients and 26 non-TB controls gained an accuracy of 81.59% (sensitivity 78.57% and specificity 84.62%) for diagnosing SNPTB. Special proteins/peptides may change in SPPTB and SNPTB patients and those changes may be used to distinguish them with the proper discriminant analytical method and to pursue and identify some involved proteins underlying the biological process of tuberculosis.
引用
收藏
页码:15 / 23
页数:8
相关论文
共 50 条
  • [31] Sputum smears for diagnosis of smear-positive pulmonary tuberculosis
    Harries, AD
    Kamenya, A
    Subramanyam, VR
    Salaniponi, FM
    Nyangulu, DS
    LANCET, 1996, 347 (9004): : 834 - 835
  • [32] Sputum smear examination and time to diagnosis in patients with smear-negative pulmonary tuberculosis in the Pacific
    Viney, K.
    Bissell, K.
    Tabutoa, K.
    Kienene, T.
    Linh, N. N.
    Briand, K.
    Harries, A. D.
    PUBLIC HEALTH ACTION, 2012, 2 (04): : 133 - 137
  • [33] Routine use of Gen-Probe Amplified Mycobacterium Tuberculosis Direct (MTD) Test for detection of Mycobacterium tuberculosis with smear-positive and smear-negative specimens
    Coll, P
    Garrigó, M
    Moreno, C
    Martí, N
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (09) : 886 - 891
  • [34] Quantifying the contribution of smear-negative, culture-positive pulmonary tuberculosis to nosocomial transmission
    Yang, Ya-Jen
    Pan, Sung-Ching
    Lee, Meng-Rui
    Chung, Che-Liang
    Ku, Chia-Ping
    Liao, Chi-Yu
    Tsai, Tien-Yu
    Wang, Jann-Yuan
    Fang, Chi-Tai
    Chen, Yee-Chun
    AMERICAN JOURNAL OF INFECTION CONTROL, 2024, 52 (07) : 807 - 812
  • [35] Weighing Harm in Therapeutic Decisions of Smear-Negative Pulmonary Tuberculosis
    Moreira, Juan
    Bisig, Bettina
    Muwawenimana, Petronille
    Basinga, Paulin
    Bisoffi, Zeno
    Haegeman, Frank
    Kishore, Panduru
    Van den Ende, Jef
    MEDICAL DECISION MAKING, 2009, 29 (03) : 380 - 390
  • [36] A STUDY OF THE CHARACTERISTICS AND COURSE OF SPUTUM SMEAR-NEGATIVE PULMONARY TUBERCULOSIS
    不详
    TUBERCLE, 1981, 62 (03): : 155 - 167
  • [37] Retrospective Review of Management of Smear-negative Pulmonary Mycobacterium Tuberculosis
    Oudah, M.
    De Rijn, J. Van
    Fassas, S.
    Baram, D.
    Alsaggaf, M.
    Yee, R.
    Milojevic, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [38] Diagnosing Pulmonary Tuberculosis In Spontaneous Sputum Smear-Negative Patients
    Shah, N. M.
    Haria, B.
    Breen, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [39] True status of smear-positive pulmonary tuberculosis defaulters in Malawi
    Kruyt, ML
    Kruyt, ND
    Boeree, MJ
    Harries, AD
    Salaniponi, FM
    van Noord, PA
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1999, 77 (05) : 386 - 391
  • [40] Analysis of chemotherapy result in new smear-positive pulmonary tuberculosis
    Cheng, S
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1147 - 1147